Skip to main content
Biohaven Ltd. logo

Biohaven Ltd. — Investor Relations & Filings

Listed
Ticker · BHVN ISIN · VGG111961055 LEI · 5299007STZTNN32O9920 US Manufacturing
Open in API
Filings indexed 241 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country VG Virgin Islands (British)
Listing US BHVN

About Biohaven Ltd.

https://www.biohaven.com/

Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas of focus are neuroscience, immunology, and oncology. Biohaven is advancing a portfolio of late- and early-stage drug development programs, building upon its legacy of success in transforming migraine treatment with Nurtec® ODT (rimegepant) and Zavzpret® (zavegepant). The company utilizes proprietary drug development platforms and combines internal research with intellectual property licensed from global institutions to address a broad range of rare and common diseases.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 85% confidence The document is a Form 8-K “Current Report” under the Securities Exchange Act (Section 13 or 15(d)), disclosing Regulation FD press releases and furnishing an investor presentation as exhibits. It is a regulatory announcement of events/materials and not the substantive financial report itself. Therefore it falls under Regulatory Filings (RNS).
2026-05-27 English
424B5 - Biohaven Ltd. (0001935979) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a detailed SEC prospectus supplement on Form 424(b)(5) relating to an at-the-market offering of up to $350 million of common shares under an existing equity distribution agreement. It describes terms of sale, use of proceeds, dilution, plan of distribution, risk factors, etc. This is clearly a financing activity update (a securities offering), not a regular annual/quarterly report or proxy. Therefore it falls under Capital/Financing Update (CAP).
2026-05-04 English
4 - Biohaven Ltd. (0001935979) (Issuer)
Director's Dealing
2026-03-19 English
4 - BIOHAVEN LTD. (0001935979) (Filer)
Director's Dealing
2026-03-04 English
4 - BIOHAVEN LTD. (0001935979) (Filer)
Director's Dealing
2026-03-04 English
4 - BIOHAVEN LTD. (0001935979) (Filer)
Director's Dealing
2026-03-04 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.